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ABSTRACT
It was found that NaH suspension in DMSO was highly activated when reacted with an alcohol. The
in situ generated NaH/alkoxide mixture permitted very rapid and complete deprotonation and
acylation of various cyclic ketones with alkyl carbonates at ambient temperature. Activated NaH/
alkoxide in DMSO is particularly effective in Dieckmann condensations, where it affords 5- and 6-
membered carbocyclic or N-containing heterocyclic β-keto esters in high yields. A heterocyclic
Dieckmann condensation was performed on a molar scale, demonstrating the scalability of the
procedure. Besides, DMSO is non-toxic, relatively inexpensive and environmentally benign solvent.
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1. Introduction
β-Keto esters are important synthetic precursors widely
used in laboratory (1) and industrial syntheses (2,3). The
compounds are very often prepared by the acylation of
preformed ketone enolate anions using reagents such as
Weinreb amides (4), alkyl-cyanoformates (5,6) or 1-Boc-imi-
dazole (7), as well as alkyl carbonates at elevated tempera-
ture (8–11). Dieckmann condensation (12) of various
diesters provides good yields of 5- and 6-membered carbo-
cyclic (13–15) or heterocyclic β-keto esters (16–21) while
acyclic analogues result from Claisen ester condensation
(22) typically after prolonged heating in aromatic solvents
with alkoxides. Alternatively, the acylation is promoted by
Lewis acids (23,24). Several examples of deprotonation, acy-
lation and/or cyclization of ketones (25) in DMSO, using
NaH at elevated temperatures (50–90°C), have been
reported previously. The use of DMSO as a solvent offers
distinct advantages in nucleophilic substitutions, elimin-
ation and related reactions (26–28); however, it reacts
rapidly with NaH at ∼50°C, forming highly nucleophilic
dimsyl anion (29). Certain ketones were acylated with
alkyl carbonates in DMSO, using alkoxide base (30).
Therefore, this work was aimed to develop an efficient
and general preparative method for both the ketone
acylation and Dieckmann condensation, avoiding hazar-
dous solvents and elevated temperatures.
2. Results and discussion
In connection with our research projects, we needed
multigram quantities of various carbocyclic and hetero-
cyclic β-keto esters (Tables 1 and 2). However, available
literature procedures for ketone acylation with alkyl car-
bonates using NaH in benzene (8) or NaH/dry KH in THF
(9) resulted, in our hands, in slow conversions, difficult to
separate mixtures and low to moderate yields. In
addition, benzene and dry KH are particularly hazardous
chemicals. While Dieckmann condensation of various
amino-diesters (Table 2) using alkoxide bases often
afforded heterocyclic β-keto esters in 70–90% yields, it
required 3–5 h of reflux in toluene or xylenes. More sig-
nificantly, under the reaction conditions, a number of
the starting amino-diesters (e.g. 2a, 2d, 2e, Table 2)
formed thick gels, greatly reducing the isolated yields
and purity of the products. Therefore, we sought to
develop a more efficient and general preparative
method for both the ketone acylation and Dieckmann
condensation.
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To that end, the acylation of carbocyclic ketones with
alkyl carbonates in DMSO was reexamined, using NaH as
a base. Initial attempts resulted in exceedingly slow
deprotonation/acylation rate at ∼20°C, while at ∼40–
50°C, the reaction proceed erratically and with delayed
exotherm, often yielding numerous side products.
Further experiments involved addition of various co-sol-
vents, solid alkaline alkoxides (MeONa, EtONa, t-BuOK)
and/or free alcohols. The activity of NaH suspension in
DMSO was highly enhanced after treatment with
certain amounts of the alcohol (MeOH, EtOH, allyl,
t-BuOH). Except for t-BuOH, the alcohols were chosen
according to the alkyl carbonate used, to prevent trans-
esterification. Subsequent addition of ketone/alkyl car-
bonate mixture resulted in immediate deprotonation/
acylation at ∼20°C, as evidenced by vigorous H2 evol-
ution and aliquot analysis. Variations in molar amounts
of NaH and alcohol relative to the ketone gave the
optimal NaH/alcohol/ketone molar ratio of ∼2.5:1.0:1.0,
respectively. The relative amount of NaH can be
reduced to ca. 2.0–2.1 equiv, without affecting the
yields; however the overall reaction rate was decreased
(by 20–50%). It appears that the alcohol has a dual
role, providing alkoxide as the kinetically more active
base as well as the activation of the NaH surface.
However, the complete conversion of NaH to the alkox-
ide with stoichiometric quantity of alcohol greatly
reduced the isolated yields and purity of β-keto esters.
Hence, the mixture of NaH and in situ formed alkoxide
in DMSO was found to be a particularly effective base
system, providing both rapid and irreversible deprotona-
tion of ketones, Scheme 1. Attempted use of LiH failed to
effect any reaction.
In experiments where a mixture of alcohol, ketone
and alkyl carbonate was added to a stirred NaH/
DMSO suspension, a significant reaction delay was
observed, followed by the vigorous exotherm. The
results confirm that the NaH suspension must be acti-
vated with alcohol, before the addition of reactants.
Under these conditions, complete conversion of
ketones was achieved and the corresponding β-keto
esters were isolated in excellent yields, on a 20–160
mmol scale (Table 1). Side products of undetermined
structures were detected only occasionally, when the
internal temperature exceeded ∼35°C. Use of ethyl
formate instead of alkyl carbonate provided β-formyl
derivative 3i.
The activated NaH/alkoxide suspension was equally
effective in Dieckmann condensation, providing high
yields of 5 and 6-membered β-keto esters (Scheme 2
and Table 2). Compounds 3b and 3d (Table 1) were
also prepared by Dieckmann condensation from the cor-
responding diesters.
Table 1. Cyclic β-keto esters prepared by acylation of ketones
1a–1g according to Scheme 1.
Cyclic ketone β-Keto estera Time(min); Scale (mmol) Yield (%)b
1a
3a 30–45; 65–160 93
1b
3b 30–45; 100 90
1c
3c 30–45; 36
90
1d
3d 30–45; 80
83
1e
3e
30–45; 80 88
1f
3f 30–45; 24
91
1g
3g
30–45; 55 95
1g c
3h
30–45; 27 85
1ad
3i
30–45; 32 95
aMethyl β-keto esters obtained with 4 eq. of dimethylcarbonate.
bIsolated yields; 1H NMR purity > 95%.
cObtained with 1.5 eq. of diallyl carbonate in DMSO/THF mixture (75:25).
dObtained with 4 eq. of ethyl formate.
Table 2. Cyclic β-keto esters prepared by Dieckmann
condensation according to Scheme 2.
Diester β-Keto ester
Time (min); Scale
(mmol)
Yield
(%)a
2a 3j
30–45; 50–500 85–95
2b 3k
180; 14 83
2c 3lb
30–60;
50–1000 87–94
2d 3m
30–45; 60
92
2e
3n
30–45; 30
88
2f 3o 30–45; 30 88–92
2g 3p 180; 30 80
2h 3q
180; 30 85
aIsolated yields; 1H NMR purity > 95%.
bReaction carried out in DMSO/THF (75:25) to prevent gel formation.
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The requisite amino-diesters 2a–2h were prepared by
aza-Michael reaction, using modified literature procedures
(31–34). Formation of 7-membered or larger rings failed,
as mixtures were obtained. Regio-selectivity was observed
in one case, affording single isomer 3p. However, com-
pounds 3n and 3owere obtained as regio-isomer mixtures.
Simple acid hydrolysis and decarboxylation of β-keto
esters 3j, 3l, 3m, 3n and 3o yielded heterocyclic
ketones 4a–4e, respectively (Scheme 2). Both the hetero-
cyclic β-keto esters and the corresponding ketones
present significant synthetic precursors (35–41). Concen-
trations of up to ∼0.4 mol/L of the reactant were
achieved, even when THF was used as a co-solvent to
prevent gel formation. DMSO was quantitatively
removed by simple aqueous extraction.
3. Conclusion
In conclusion, the use of in situ generated NaH/alkoxide
mixture in DMSO allows for a high-yielding and efficient
procedure for the Dieckmann condensation and alkoxy-
carbonylation of ketones. It is inexpensive and suitable
method for large scale preparations of various β-keto
esters. In comparison with previously reported pro-
cedures, advantages of the method described are
numerous; expediency, high yields, the operational sim-
plicity, and in addition, use of DMSO as non-toxic, non-
flammable and environmentally benign solvent which
could be quantitatively removed by simple aqueous
extraction. Other solvents used (petroleum ether,
PhMe, MeOAc or EtOAc) are also of low toxicity.
Scheme 1. Acylation of cyclic ketones with alkyl carbonates using activated NaH.
Scheme 2. Dieckmann condensation of diesters using activated NaH/DMSO.
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4. Experimental
4.1. General information
1H NMR spectra were recorded at 200 MHz or 500 MHz
and 13C NMR/APT at 50 or 126 MHz as indicated in
each case. Data are reported as chemical shifts in
δ (ppm). The chemical shift references were as follows:
1H NMR (7.26 δ, CHCl3 or 0.00 δ, TMS) and
13C NMR
(77.00 δ, CDCl3).
1H and 13C NMR spectra were Bruker
Avance 500, or Varian Gemini 2000 instruments. All
high-resolution mass spectra were obtained by ESI-ToF
and recorded on Agilent Technologies 6210-1210 TOF-
LC-ESI-HR/MS instrument in positive mode. All exper-
iments were monitored by thin-layer chromatography
on silica and/or by 1H NMR. Reagent-grade solvents
and commercial precursors (declared H2O content
<0.1%) were used without further purification. BHT
refers to 3,5-di-tert-butyl-4-hydroxytoluene. NaH was
used exclusively as a 60% mineral oil suspension. Typi-
cally, the mineral oil was washed with petroleum ether
prior to the reaction, using the reverse filtration under
positive pressure of Ar. In molar-scale experiments, the
washing was omitted and the mineral oil was removed
during the work-up. The reaction mixture was worked-
up with an aqueous solution of tartaric acid, followed
by pH adjustment to pH 9–10 with 20% K2CO3 solution.
Low volatile compounds (amino-diesters, most β-keto
esters and heterocyclic ketones were vacuum dried to
remove H2O and solvents (20–50°C, 0.1–0.5 mm Hg,
30–60 min) prior to the spectral analysis and determi-
nation of the yields.
4.2. Procedure
4.2.1. Typical procedure for the ketone acylation
The compounds 3a–3i were prepared according to the
typical procedure for 3a.
4.2.1.1. Methyl 5-(tert-butyl)-2-oxocyclohexanecar-
boxylate (3a, CAS No. 74851-58-4). After purging the
apparatus with Ar, MeOH (2.63 mL, 64.8 mmol) in
DMSO (3.0 mL) was added dropwise to the magnetically
stirred suspension of oil-washed NaH (60%, 6.48 g, 162
mmol) in DMSO (140 mL) at ∼20°C (H2 evolution!).
Then, 4-(tert-butyl) cyclohexanone (10.0 g, 64.8 mmol)
in dimethyl carbonate (21.8 mL, 259 mmol) was added
over 20 min at ∼20°C and stirring continued for 20
min. Excess NaH was destroyed with MeOH (5.25 mL,
0.130 mol). The reaction mixture was poured into a sol-
ution prepared from tartaric acid (12.2 g, 81 mmol),
NaCl (10 g), H2O (300 mL) and ice (100 g), and extracted
with petroleum ether/MeOAc (7:3, 3 mL × 100 mL). The
extracts were concentrated under reduced pressure
(40°C) and the obtained yellow oil was vacuum dried.
Yield: 12.8 g, 93%, yellow liquid. 1H NMR (200 MHz,
CDCl3): δ = 12.13 (s, 1H), 3.76 (s, 3H), 2.43- 2.23 (m, 3H),
1.99–1.79 (m, 2H), 1.31–1.16 (m, 2H), 0.91 ppm (s, 9H).
13C NMR (50 MHz, CDCl3): δ = 173.1, 172.0, 97.3, 51.2,
44.0, 32.1, 30.0, 27.2, 23.6, 23.0 ppm. HRMS-ToF-ESI: m/z
calcd for C12H20O3: ([M + Na]
+) 235.1304, found 235.1302.
4.2.1.2. Methyl 2-oxocyclohexanecarboxylate (3b, CAS
No. 41302–34–5). Prepared from cyclohexanone (9.82 g,
100.0 mmol). Yield (distilled, colourless liquid): 14.1 g,
90%. Alternatively prepared according to the procedure
3.3 from dimethyl heptanedioate (15.1 g, 80 mmol).
Yield: 10.7 g, 86%. 1H NMR (keto-enol mixture = 35:65;
200 MHz, CDCl3): δ = 12.15 (s), 3.74 (s), 3.74 (s), 3.40 (t, J =
7.8 Hz), 2.63–2.32 (m), 2.31–2.06 (m), 2.03–1.50 ppm (m).
13C NMR (50 MHz, CDCl3): δ= 205.6, 172.7, 171.8, 170.1,
97.1, 56.8, 51.6, 50.9, 41.1, 29.6, 28.7, 26.8, 23.0, 22.04,
22.01, 21.6 ppm. HRMS-ToF-ESI: m/z calcd for C8H13O3:
([M + H]+) 157.0859, found 157.0862.
4.2.1.3. Methyl 3-methyl-2-oxocyclohexanecarboxy-
late (3c, CAS No. 59416-90-9). Prepared from 2-methyl-
cyclohexanone (4.00 g, 36 mmol). Yield: (colourless
liquid) 5.52 g, 90%. 1H NMR (cis/trans keto-enol mixture
= 50:50; 500 MHz, CDCl3): δ = 12.29 (s), 3.75 (s), 3.74 (s),
3.73 (s), 3.45–3.41 (m), 3.39 (dd, J = 5.5, 1.1 Hz), 2.69–
2.60 (m), 2.55–2.52 (m), 2.50–2.39 (m), 2.28–2.24 (m),
2.24–2.18 (m), 2.16–2.09 (m), 2.08–2.00 (m), 1.99 (d, J =
3.8 Hz), 1.93 (ddd, J = 7.0, 3.9, 3.2 Hz), 1.90 (td, J = 3.7,
1.8 Hz), 1.85–1.56 (m), 1.56–1.46 (m), 1.46 -1.36 (m),
1.18 (d, J = 7.1 Hz), 1.07 (d, J = 6.6 Hz), 1.04 ppm (d, J =
6.5 Hz). 13C NMR/APT (126 MHz, CDCl3): δ= 208.1, 207.5,
175.4, 173.2, 170.4, 96.9, 57.4, 55.6, 52.1, 51.7, 51.2, 45.5,
43.9, 36.2, 35.4, 33.3, 30.6, 30.4, 30.1, 24.0, 22.8, 21.5,
19.9, 17.9, 14.7, 14.2 ppm. HRMS-ToF-ESI: m/z calcd for
C9H15O3: ([M + H]
+) 171.1015, found 171.1007.
4.2.1.4. Methyl 2-oxocyclopentanecarboxylate (3d,
CAS No 10472-24-9). Prepared from cyclopentanone
(6.73 g, 80.0 mmol). Yield (distilled, colourless liquid):
83%, 9.48 g. Alternatively prepared acc. to the procedure
for 4.3, from dimethyl adipate (13.9 g, 80 mmol). Yield:
9.21 g, 81%. 1H NMR (keto-enol mixture = 95:5; 200
MHz, CDCl3): δ = 10.34 (s), 3.75 (s), 3.74 (s, 3H), 3.18 (t, J
= 9.0 Hz, 1H), 2.40–2.22 (m, 4H), 2.22–2.03 (m, 1H), 2.02
-1.77 ppm (m, 1H). 13C NMR (50 MHz, CDCl3): δ = 212.1,
169.6, 54.3, 52.1, 37.7, 27.1, 20.6 ppm.
4.2.1.5. Methyl 2-oxocycloheptanecarboxylate (3e,
CAS No. 52784-32-4). Prepared from cycloheptanone
(8.97 g, 80.0 mmol). Yield (colourless liquid): 12.0 g,
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88%. 1H NMR (keto-enol mixture = 75:25; 200 MHz,
CDCl3): δ = 12.66 (s), 3.75 (s), 3.72 (s), 3.57 (dd, J = 10.1,
4.0 Hz), 2.67–2.53 (m), 2.49–2.35 (m), 2.20–2.03 (m),
2.03–1.81 (m), 1.80–1.55 (m), 1.55–1.37 ppm (m). 13C
NMR (50 MHz, CDCl3): δ = 208.6, 179.4, 170.7, 101.2,
58.5, 51.8, 51.1, 42.8, 35.0, 31.7, 29.3, 27.7, 27.3, 27.1,
24.3, 24.1 ppm.
4.2.1.6. Methyl 2-oxocyclooctanecarboxylate (3f, CAS
No. 5452-73-3). Prepared from cyclooctanone (3.00 g,
23.8 mmol). Yield (vacuum dried, yellow liquid): 3.97 g,
91%. 1H NMR (keto-enol mixture = 43:57; 200 MHz,
CDCl3): δ= 12.51 (s), 3.75 (s), 3.69 (s), 3.65–3.54 (m),
2.69–2.46 (m), 2.46–2.28 (m), 2.18–2.03 (m), 1.98–1.81
(m), 1.81–1.62 (m), 1.62–1.33 ppm (m). 13C NMR (50
MHz, CDCl3): δ = 211.9, 176.0, 173.2, 170.4, 98.9, 56.6,
52.0, 51.2, 41.6, 32.0, 29.7, 28.9, 28.5, 26.9, 26.3, 25.9,
25.2, 25.0, 24.4, 23.7 ppm. HRMS-ToF-ESI: m/z calcd for
C10H16O3: ([M + H]
+) 185.1172, found 185.1164.
4.2.1.7. Methyl 2-oxocyclododecanecarboxylate (3g,
CAS No. 62939-87-1). Prepared from cyclododecanone
(10.0 g, 54.8 mmol). Yield (vacuum dried, yellow liquid):
12.5 g, 95% 1H NMR: (keto:enol mixture = 90:10; 200
MHz, CDCl3): δ = 12.84 (s), 3.76 (s), 3.70 (s), 3.64 (dd, J =
11.4, 3.5 Hz), 2.79–2.39 (m), 2.39–2.02 (m), 2.01–1.66
(m),1.65–1.47 (m), 1.45 -1.09 ppm (m). 13C NMR (50
MHz, CDCl3): δ = 206.5, 175.6, 170.3, 57.0, 52.1, 51.3,
40.2, 38.4, 28.6, 27.6, 26.7, 25.4, 25.3, 25.0, 24.6, 24.5,
24.5, 24.2, 24.1, 24.0, 23.6, 23.1, 22.9, 22.4, 22.2, 21.9
ppm. HRMS-ToF-ESI: m/z calcd for C14H24O3: ([M + Na]
+)
263.1617, found 263.1620.
4.2.1.8. Allyl 2-oxocyclododecanecarboxylate (3h, CAS
No. 97416-37-0). Prepared from cyclododecanone (4.92
g, 27 mmol), allyl alcohol and diallyl carbonate (5.70 g,
40 mmol) in DMSO/THF (8:2). Yield (vacuum dried,
yellow liquid): 85–90% (over several runs). 1H NMR
(keto-enol mixture = 90:10; 500 MHz, CDCl3): δ = 12.82
(s), 5.92–5.83 (m), 5.31 (dd, J = 2.9, 1.4 Hz), 5.28 (dd, J =
2.9, 1.4 Hz), 5.24 (dd, J = 2.4, 1.2 Hz), 5.22 (dd, J = 2.4,
1.2 Hz), 4.59 (dd, J = 2.6, 1.3 Hz), 4.58 (dd, J = 2.6, 1.3
Hz), 3.64 (dd, J = 11.5, 3.4 Hz), 2.67 (ddd, J = 16.2, 11.0,
3.4 Hz), 2.56 (dd, J = 6.8, 3.4 Hz), 2.53 (dd, J = 6.8, 3.4
Hz,), 2.48–2.42 (m), 2.32 (t, J = 7.6 Hz), 2.25 (t, J = 6.8 Hz),
2.21–2.10 (m), 1.95–1.82 (m), 1.82–1.65 (m), 1.61–1.50
(m), 1.44–1.17 ppm (m). APT (126 MHz, CDCl3): δ =
206.5, 169.5, 132.3, 131.5, 118.8, 117.6, 65.8, 64.7, 57.3,
40.3, 38.5, 26.8, 25.4, 25.1, 24.6, 24.3, 24.2, 24.1, 24.1,
23.0, 22.5, 22.3, 22.0 ppm. HRMS-ToF-ESI: m/z calcd for
C16H26O3: ([M + K]
+) 305.1513, found 305.1509.
4.2.1.9. 5-(Tert-butyl)-2-oxocyclohexanecarbaldehyde
(3i, CAS No. 22252-96-6). Prepared from 4-(tert-butyl)
cyclohexanone (5.00 g, 32.4 mmol), HCO2Et (10.5 mL,
130 mmol) and MeOH. Yield (gelatinous reddish solid,
vacuum dried): 95%, 5.61 g. 1H NMR (200 MHz, CDCl3):
δ = 14.35 (s, 1H), 8.68 (s, 1H), 2.52–2.24 (m, 3H), 2.16–
1.76 (m, 2H), 1.41–1.15 (m, 2H), 0.93 ppm (s, 9H). 13C
NMR (50 MHz, CDCl3): δ = 188.1, 184.2, 108.5, 44.4, 32.2,
31.9, 27.1, 24.3, 22.3 ppm. HRMS-ToF-ESI: m/z calcd for
C11H18O2: ([M + H]
+) 183.1379, found 183.1373.
4.2.2. Typical procedure for the Dieckmann
condensation
The compounds 3j–3q were prepared according to the
typical procedure for 3j, using the appropriate alcohol
(MeOH, EtOH or t-BuOH. The compound 3l was prepared
in DMSO/THF mixture (75:25) to prevent formation of a
gel. In the case of di-t-butyl esters (2b, 2h), the onset
of H2 evolution was delayed during t-BuOH addition
(5–10min) and the reaction required 2–4h to complete.
4.2.2.1. Methyl 1-benzyl-4-oxopiperidine-3-carboxy-
late (3j, CAS No. 57611-47-9). After purging the appar-
atus with Ar, MeOH (2.00 mL 50.0 mol,) in DMSO (3.0 mL)
was added dropwise to the magntically stirred suspen-
sion of oil-washed NaH (60%, 5.00 g, 125 mmol) in
DMSO (120 mL) at ∼20°C (H2 evolution!).Then, a solution
of diester 2a (14.00 g, 50.0 mmol) in DMSO (10 mL) was
added over 15 min at ∼20°C and stirring continued for
15 min. The reaction rate was monitored by hydrogen
evolution. Excess NaH was destroyed with MeOH (2.00
mL, 50.0 mmol). The reaction mixture was poured into
the buffer solution prepared from tartaric acid (9.40 g,
62.5 mmol), NaCl (10 g), H2O (300 mL) and ice (100 g),
followed by PhMe extraction (3 mL × 100 mL). The
extracts were concentrated (rotatory evaporator), then
vacuum dried. Yield (yellow oil): 11.35 g, 92%. The com-
pound slowly decomposes at ∼20°C and was storied at
−20°C. Over several runs, on 20–100 mmol scale, isolated
yields were 82–95%. 1H NMR (keto-enol mixture = 30:70;
200 MHz, CDCl3): δ = 11.95 (s), 7.43–7.16 (m), 3.71 (s), 3.70
(s), 3.62 (s), 3.54–3.43 (m), 3.17 (t, J = 1.5 Hz), 3.08–2.65
(m), 2.63–2.54 (m), 2.38 ppm (t, J = 5.9 Hz).13C NMR (50
MHz, CDCl3): δ=203.9, 171.2, 170.3, 169.1, 137.9, 137.6,
128.9, 128.7, 128.2, 127.3, 127.1, 96.6, 62.0, 61.4, 56.3,
54.8, 52.9, 52.0, 51.2, 49.7, 48.6, 40.6, 29.2 ppm. HRMS-
ToF-ESI: m/z calcd for C14H17NO3: ([M + H]
+) 248.1281,
found 248.1275.
4.2.2.2. Tert-butyl 1-benzyl-4-oxopiperidine-3-carbox-
ylate (3k, new compound). Prepared from 2b (5.00 g,
13.7 mmol). Yield (amorphous white mass): 3.29 g, 83%.
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1H NMR (500 MHz, CDCl3), (keto-enol mixture = 10:90),
enol form only: δ = 12.16 (s, 1H), 7.55–7.03 (m, 5H), 3.62
(s, 2H), 3.17 (t, J = 1.6 Hz, 2H), 2.56 (t, J = 5.9 Hz, 2H),
2.35 (tt, J = 5.9, 1.6 Hz, 2H), 1.48 ppm (s, 9H). 13C NMR
(126 MHz, CDCl3): δ = 204.6, 170.8, 169.6, 168.1, 138.1,
137.9, 129.0, 128.8, 128.3, 128.2, 127.3, 127.1, 97.8, 81.8,
81.1, 62.0, 61.6, 57.2, 55.4, 53.1, 50.5, 48.3, 40.6, 29.4,
28.1, 27.9 ppm. HRMS-ToF-ESI: m/z calcd for C17H23NO3:
([M + H]+) 290.1750, found 290.1753.
4.2.2.3. Methyl 4-oxo-1-phenethylpiperidine-3-carbox-
ylate (3i, CAS No. 66670-11-9). Prepared from 2c (293.4
g, 1.00 mol), in DMSO/THF (75/25, 2L), using sealed
mechanical stirrer. Yield (yellow oil): 247.9 g (95%). 1H
NMR (keto-enol mixture = 30:70; 500 MHz, CDCl3): δ =
11.92 (s), 7.35–7.15 (m), 3.76 (s), 3.75 (s), 3.48 (ddd, J =
7.8, 4.9, 1.2 Hz), 3.23 (t, J = 1.6 Hz), 3.16 (ddd, J = 11.6,
7.8, 1.1 Hz), 3.01 (ddd, J = 11.7, 4.9, 1.7 Hz), 2.92–2.77
(m), 2.77–2.71 (m), 2.69 (t, J = 5.9 Hz), 2.63 (dd, J = 6.4,
4.9 Hz), 2.60 (dd, J = 6.4, 4.9 Hz), 2.57–2.49 (m), 2.44
ppm (tt, J = 5.8, 1.6 Hz).13C NMR (126 MHz, CDCl3): δ =
203.70, 171.18, 170.19, 169.11, 139.93, 139.71, 128.52,
128.25, 126.01, 125.94, 96.39, 59.50, 58.55, 56.16, 54.91,
53.07, 52.07, 51.20, 49.42, 49.19, 40.49, 33.85, 33.67,
29.21 ppm. HRMS-ToF-ESI: m/z calcd for C15H19NO3: ([M
+ H]+) 262.1437, found 262.1433.
4.2.2.4. Ethyl 1-benzyl-5-methyl-4-oxopiperidine-3-
carboxylate (3m, CAS No. 93614-12-1). Prepared from
2d (60 mmol, 19.3 g). Yield (yellow oil): 15.1 g, 92%
(Note: the obtained mixture [cis/trans stereoisomers
and keto-enol tautomers] gave poorly resolved 1H NMR
[200 MHz, CDCl3, in Supplementary information] and
was further characterized by acidic hydrolysis/decarbox-
ylation to ketone 4c). 13C NMR (50 MHz, CDCl3): δ = 206.4,
205.6, 173.9, 171.3, 168.6, 138.3, 137.9, 137.8, 128.8, 128.7,
128.4, 128.2, 127.4, 127.3, 127.1, 96.2, 62.0, 61.5, 61.3,
60.9, 60.9, 60.7, 60.2, 56.3, 56.2, 56.0, 55.7, 55.5, 50.7,
44.1, 43.5, 34.1, 15.8, 14.2, 14.0, 14.0, 12.0, 11.2 ppm.
HRMS-ToF-ESI: m/z calcd for C16H21NO3: ([M + H]
+)
276.1594, found 276.1583.
4.2.2.5. Compound 3n (equimolar mixture of methyl 1-
benzyl-6-methyl-4-oxopiperidine-3-carboxylate [new
compound] and methyl 1-benzyl-2-methyl-4-oxopiper-
idine-3-carboxylate [new compound]). Prepared from
2e (8.80 g, 30 mmol). Yield (yellow oil): 6.92 g, 88%.
[Note: the obtained mixture (cis/trans stereoisomers
and keto-enol tautomers) gave poorly resolved 1H NMR
(200 MHz, CDCl3, in Supporting information) and was
further characterized by acidic hydrolysis/decarboxyla-
tion to ketone 4d. 13C NMR (50 MHz, CDCl3): δ = 204.6,
204.0, 203.7, 171.8, 171.3, 170.5, 169.5, 169.4, 139.0,
138.9, 138.5, 138.5, 128.5, 128.4, 128.1, 127.1, 126.8,
102.0, 95.6, 63.0, 57.6, 57.5, 57.1, 56.6, 56.5, 56.1, 56.0,
56.0, 55.6, 51.9, 51.8, 51.4, 51.1, 51.0, 50.8, 50.5, 50.1,
48.1, 47.2, 47.1, 45.1, 40.7, 39.5, 35.3, 26.6, 17.9, 16.4,
16.3, 13.9, 13.7 ppm. HRMS-ToF-ESI: m/z calcd for
C15H19NO3: ([M + H]
+) 262.1437, found 262.1440.
4.2.2.6. Compound 3o (equimolar mixture of ethyl 1-
benzyl-3-oxopyrrolidine-2-carboxylate, CAS No.
329956-59-4 and ethyl 1-benzyl-4-oxopyrrolidine-3-
carboxylate, CAS No. 1027-35-6). Prepared from 2f
(8.80.g, 30 mmol) and it was not separated. Yield
(yellow oil): 6.69 g, 90%. 1H NMR (200 MHz, CDCl3) δ =
7.34–7.02 (m), 4.26–4.04 (m), 3.95–3.59 (m), 3.55–3.19
(m), 3.07 (t, J = 8.9 Hz), 2.95–2.43 (m), 1.43–1.06 ppm
(m). 13C NMR (50 MHz, CDCl3): δ = 206.4, 167.3, 136.9,
129.3, 128.6, 128.4, 128.3, 127.5, 127.4, 72.2, 61.5, 61.4,
60.9, 60.0, 58.2, 54.4, 53.9, 48.2, 40.7, 37.1, 14.0 ppm.
HRMS-ToF-ESI: m/z calcd for C14H17NO3: ([M + H]
+)
248.1281, found 248.1283.
4.2.2.7. Tert-butyl 1-benzyl-3-oxopyrrolidine-2-car-
boxylate (3p, CAS No. 329956-61-8). Prepared from
2g (9.64 g, 30 mmol). Yield (amorphous white mass):
7.25 g, ca. 85%, contaminated with a single impurity,
ca. 5% acc. to 1H NMR). 1H NMR (500 MHz, CDCl3): δ =
7.49–7.14 (m, 5H), 3.95 (d, J = 13.0 Hz, 1H), 3.73 (d, J =
12.9 Hz, 1H), 3.46 (s, 1H), 3.31 (td, J = 8.6, 3.7 Hz, 1H),
2.72 (dd, J = 16.5, 8.3 Hz, 1H), 2.60–2.50 (m, 1H), 2.45
(dd, J = 7.4, 3.7 Hz, 1H), 2.41 (dd, J = 7.4, 3.7 Hz, 1H),
1.45 ppm (s, 9H). 13C NMR (126 MHz, CDCl3): δ = 207.8,
166.4, 136.5, 129.1, 128.3, 127.4, 82.1, 72.6, 57.8, 48.0,
37.1, 27.8 ppm. HRMS-ToF-ESI: m/z calcd for C16H21NO3:
([M + H]+) 276.1594, found 276.1596.
4.2.2.8. Tert-butyl 2-oxocyclohexanecarboxylate (3q,
CAS No. 55623-56-8). Prepared from di-tert-butyl hepta-
nedioate (8.00 g, 29.4 mmol). Yield (distilled colourless
liquid): 4.95 g, 85%. 1H NMR (keto-enol mixture = 30:70;
200 MHz, CDCl3): δ = 12.40 (s), 3.33–3.20 (m), 2.58–2.31
(m), 2.30–2.10 (m), 1.94–1.75 (m), 1.74–1.53 (m), 1.50 (s),
1.48 ppm (s). 13C NMR (50 MHz, CDCl3): 206.7, 172.6,
171.2, 169.2, 98.8, 81.4, 80.5, 57.8, 41.4, 29.9, 29.0, 28.1,
27.9, 27.0, 23.0, 22.7, 22.4, 21.9 ppm. HRMS-ToF-ESI: m/z
calcd for C11H18O3: ([M + K]
+) 237.0887, found 237.0878.
4.2.3. Typical procedure for the preparation of
heterocyclic ketones (piperidones and pyrrolidones)
The compounds 4a–4e were prepared according to the
typical procedure for 4a.
4.2.3.1. 1-Benzyl-piperidin-4-one (4a, CAS No. 3612-
20-2). Compound 3j (12.4 g, 50 mmol) was dissolved in
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aqueous HCl (28–30%, 80 mL) and heated to reflux with
magnetic stirring for 2–3 h (vigorous CO2 and HCl evol-
ution!). The reaction mixture was cooled to ∼20°C,
poured on the crashed ice (50 g) and alkalized to pH
∼10 with 20% NaOH solution at 15–25°C (strongly
exothermic!). The resulting biphasic mixture was
extracted with toluene (2 mL × 50 mL), concentrated
(rotatory evaporator) and vacuum dried (0.1–0.3
mmHg, ∼20°C, 30 min). Yield: (yellow liquid): 8.75 g,
92%, 1H NMR (200 MHz, CDCl3): δ = 7.39–7.20 (m, 5H),
3.60 (s, 2H), 2.72 (t, J = 6.1 Hz, 4H), 2.43 ppm (t, J = 6.1
Hz, 4H). 13C NMR (50 MHz, CDCl3): δ = 209.0, 138.0,
128.7, 128.2, 127.1, 61.7, 52.7, 41.1 ppm.
4.2.3.2. 1-Phenethylpiperidin-4-one (4b, CAS No.
39742-60-4). Prepared from 3l (247.9 g, 0.95 mol). Esti-
mated purity (1H NMR): >95%. Yield (yellow solid):
184.2 g, 91%. 1H NMR (200 MHz, CDCl3): δ = 7.58–6.94
(m, 5H), 2.88–2.78 (m, 6H), 2.76–2.69 (m, 2H), 2.47 ppm
(t, J = 6.2 Hz, 4H). 13C NMR (50 MHz, CDCl3): δ = 208.69,
139.78, 128.44, 128.21, 125.94, 58.99, 52.78, 40.96,
33.86 ppm. HRMS-ToF-ESI: m/z calcd for C13H17NO: ([M
+ H]+) 204.1382, found 204.1385.
4.2.3.3. 1-Benzyl-3-methylpiperidin-4-one (4c, CAS No.
34737-89-8). Prepared from 3m (30 mmol, 8.26 g) Yield:
(yellow liquid) 5.35 g, 88%. 1H NMR (200 MHz, CDCl3): δ =
7.38–7.22 (m, 5H), 3.60 (s, 2H), 3.20–2.95 (m, 2H), 2.74–
2.24 (m, 4H), 2.09 (t, J = 11.1 Hz, 1H), 0.99 ppm (d, J =
6.7 Hz, 3H). 13C NMR (50 MHz, CDCl3): δ = 211.0, 138.1,
128.8, 128.3, 127.2, 61.7, 60.6, 53.6, 44.2, 40.8, 11.8 ppm.
HRMS-Tof-ESI: m/z calcd for C13H17NO: ([M + H]
+)
204.1382, found 204.1392.
4.2.3.4. 1-Benzyl-2-methylpiperidin-4-one (4d CAS No.
203661-73-8). Prepared from 3n (7.84 g, 30 mmol)
Yield (yellow liquid): 5.20 g, 85%. 1H NMR (200 MHz,
CDCl3): δ = 7.39–7.22 (m, 5H), 3.94 (d, J = 13.5 Hz, 1H),
3.43 (d, J = 13.4 Hz, 1H), 3.09–2.79 (m, 2H), 2.66–2.42
(m, 2H), 2.39–2.20 (m, 3H), 1.15 ppm (d, J = 6.4 Hz, 3H).
13C NMR (50 MHz, CDCl3): δ = 209.3, 138.8, 128.5, 128.2,
126.9, 56.8, 55.9, 48.5, 48.3, 40.6, 17.2 ppm. HRMS-ToF-
ESI: m/z calcd for C13H17NO: ([M + H]
+) 204.1382, found
204.1384.
4.2.3.5. 1-Benzylpyrrolidin-3-one (4e, CAS No. 775-16-
6). Prepared from 3o (30 mmol, 7.42 g). Yield: (yellow
liquid) 4.40 g, 84%. The compound was relatively
unstable and was kept at −20°C. 1H NMR (200 MHz,
CDCl3): δ = 7.55–7.08 (m, 5H), 3.70 (s, 2H), 3.07–2.68 (m,
4H), 2.38 ppm (t, J = 6.8 Hz, 2H). 13C NMR (50 MHz,
CDCl3): δ = 213.8, 137.2, 128.6, 128.2, 127.2, 61.2, 60.4,
51.0, 37.7 ppm.
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